A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy.

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

NSABP B-51/RTOG 1304
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy.

Genetic testing for men with metastatic prostate cancer. This study seeks to remove barriers and improve access to genetic testing and counseling, which aren’t available everywhere or always covered by insurance.

Survivorship FH2550
A multicenter study to assess late and long-term effects of cancer treatment and to improve and expand care among cancer survivors.

RTOG 3515  Early Stage NSCLCa SBRT with Durvalumab NCT03703297
A Phase III International study for persons with early stage Non-Small Cell Lung Cancer who are not surgery candidates. The cancer will be treated with Stereotactic Body Radiation Therapy (SBRT) followed by the randomized, double blind, placebo-controlled use of Durvalumab (immunotherapy).